Related Experiment Video
Updated: Jan 11, 2026

08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
17.4K
Utilizing Machine Learning to Identify Predictors of Corticosteroid Discontinuation 1-Year After Adult Heart
Caroline Chen1, Zeina Jedeon2, Abhishek Jaiswal2,3
1Department of Pharmacy Practice, University of Connecticut School of Pharmacy, Storrs, Connecticut, USA.
Pharmacotherapy
|November 11, 2025
Summary
Machine learning identified key factors for discontinuing corticosteroid (CS) therapy one year after heart transplantation (HT). Lower transplant center volume, shorter donor ischemia time, and LVAD use predicted CS cessation.
Area of Science:
- Cardiology
- Immunology
- Data Science
Background:
- Corticosteroids (CS) are crucial post-heart transplantation (HT) but associated with adverse effects.
- Identifying predictors of CS discontinuation is vital for optimizing long-term outcomes.
Purpose of the Study:
- To leverage machine learning (ML) to identify factors associated with CS discontinuation 1-year post-adult HT.
- To develop a predictive model for CS cessation using recipient, donor, and transplant variables.
Main Methods:
- Retrospective analysis of the United Network for Organ Sharing (UNOS) database.
- Utilized eXtreme Gradient Boosting (XGBoost) and Shapley Additive Explanations (SHAP) for predictive modeling and feature importance.
- Included 72,730 adult first-time HT recipients discharged on CS.
Main Results:
- 17.9% of recipients discontinued CS within 1 year.
- Predictors of CS discontinuation included lower transplant center volume, shorter donor ischemic time, and LVAD use at transplant.
- The XGBoost model demonstrated strong performance (AUC=0.854).
Conclusions:
- Machine learning effectively identified key predictors of 1-year CS discontinuation post-heart transplant.
- Transplant center volume, donor ischemia time, and LVAD use are significant factors influencing CS cessation.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
315
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
315
Kidney Transplant III: Nursing Management
301
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
301
Tissue Transplantation
883
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
883

